Trials / Unknown
UnknownNCT05887180
PräVaNet - Structured, Intersectoral, Multiprofessional, Digitized Program to Optimize Cardiovascular Prevention
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 209 (actual)
- Sponsor
- Charite University, Berlin, Germany · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
PräVaNet is a prospective, 1:1 randomized, controlled trial to investigate the efficacy of a new, digitalized prevention strategy ("ePrevention") in cardiovascular high-risk patients with type 2 diabetes mellitus in the outpatient sector.
Detailed description
PräVaNet is an interdisciplinary and digitally supported prevention concept based on a specialist online board, close patient care by a specially trained nurse, an E-Health platform with physician cockpit, patient App, a smart sensor kit (ECG-capable pulse watch, digital blood pressure monitor, digital blood glucose meter if required) and a telemonitoring/alarm system. The aim of PräVaNet is to prevent a worsening of the condition of cardiovascular high-risk patients with type 2 diabetes through intensified and continuous risk factor monitoring as well as guideline- and needs-based patient treatment and care. Serious, cost-intensive (especially cardiovascular) secondary diseases are to be avoided and the quality of life of those affected is to be maintained or improved. PräVaNet includes intensive patient education to improve personal responsibility and self-management of the disease and the individual cardiovascular risk. PräVaNet is the first clinical study evaluating effectiveness and safety of an ePrevention-concept in cardiovascular high-risk patients with type 2 diabetes mellitus in Germany.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | PräVaNet-Intervention | interdisciplinary and digitally supported prevention concept |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2024-06-30
- Completion
- 2025-06-30
- First posted
- 2023-06-02
- Last updated
- 2023-06-07
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05887180. Inclusion in this directory is not an endorsement.